Activist 13D/13G Filings - Third Rock Ventures IV L.P.

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Reported
DateTime
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportFiling
2024-09-04
8:45 pm
Sale
13DTango Therapeutics Inc.
TNGX
Third Rock Ventures IV L.P.17,001,475
15.900%
-2,362,500decrease
(-12.20%)
View
2024-02-14
4:15 pm
Unchanged
13GDIANTHUS THERAPEUTICS INC
DNTH
Third Rock Ventures IV L.P.0
0.000%
0
(Unchanged)
View
2022-02-14
4:53 pm
Purchase
13GDIANTHUS THERAPEUTICS INC
DNTH
Third Rock Ventures IV L.P.6,758,204
11.500%
6,758,204increase
(New Position)
View
2021-08-19
4:35 pm
Purchase
13DTango Therapeutics Inc.
TNGX
Third Rock Ventures IV L.P.19,363,975
22.100%
19,363,975increase
(New Position)
View
2020-02-05
4:33 pm
Purchase
13GFulcrum Therapeutics Inc.
FULC
Third Rock Ventures IV L.P.2,343,154
10.000%
2,343,154increase
(New Position)
View